Clinical trial

Subjective Efficacy of Ramelteon on Sleep in Adults With Chronic Insomnia.

NCT00414102 · Takeda, Industry · Completed

Key facts

NCT number NCT00414102
Title Subjective Efficacy of Ramelteon on Sleep in Adults With Chronic Insomnia.
Official title A Randomized, Double Blind, Placebo-Controlled, Parallel Group Study to Demonstrate the Subjective Treatment Effects of Ramelteon on Sleep Using a Post Sleep Questionnaire - Interactive Voice Response System (PSQ-IVRS) in an "At-Home Setting" in an Adult Population With Chronic Insomnia
Lead sponsor Takeda, Industry
Status Completed
Phase Phase 4
Study type Interventional
Conditions Chronic Insomnia
Intervention type Drug
Interventions Ramelteon, Placebo
Enrollment 552
Start date Oct 1, 2006
Primary completion Sep 1, 2007
Completion Sep 1, 2007
First posted Dec 21, 2006
Last update posted Jun 28, 2016
Countries United States

At a glance

  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies